ADIM
CBRE icon

Alpha DNA Investment Management’s CBRE Group CBRE Stock Holding History

Alpha DNA Investment Management’s Portfolio CBRE Stock Details CBRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,711
Closed -$135K – 181
2021
Q1 		$135K Buy
+1,711
New +$121K 0.16% 113

Other funds holding CBRE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alpha DNA Investment Management's CBRE Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of CBRE Group (CBRE) in Q2 2021, closing a stake of 1,711 shares — an estimated $135K sold.

Alpha DNA Investment Management first reported a position in CBRE in Q1 2021 and held it in 1 quarter. The position peaked at $135K in Q1 2021. 670 funds tracked by Wall St. Rank hold CBRE as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining CBRE Group position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 1,711 CBRE Group shares in Q2 2021, an estimated $135K.
  • Alpha DNA Investment Management first reported a position in CBRE Group in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's CBRE Group position peaked at $135K in Q1 2021.
  • 670 funds tracked by Wall St. Rank held CBRE Group as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.